The US Supreme Court has ruled that pharmaceutical and biotechnology companies cannot patent a human gene, even if they’re the first to discover it.
The decision could affect research and development of future drugs and other medical products, especially here in New York City, home to many medical and scientific research facilities.
"I think it's a two-headed decision," said Nathan Tinker, executive director of New York BIO, the state trade group for the biotech industry. "On the one hand, the Supreme Court said you cannot patent isolated DNA ... on the other hand, though, they did protect the diagnostics, therapeutics, and other products that may come out of that."
To hear Host Amy Eddings' full conversation with Nathan Tinker, click on the audio above.